CMS withdraws Medicare billing changes for Orthofix bone growth stimulators; reimbursement restored to prior rates

Orthofix Medical Inc.

• On July 1, 2026, CMS issued revised guidance withdrawing May 18, 2026 billing changes for HCPCS codes E0747, E0748, E0760.
• Orthofix expects average Medicare reimbursement for these codes to return to rates in effect prior to May 18, 2026.
• The reversal follows FDA's April 16, 2026 reclassification of non-invasive bone growth stimulators from Class III to Class II.
• The prior CMS changes had modified billing requirements and Medicare fee schedule treatment; now withdrawn.